Hydroxyapatite composite sodium hyaluronate for alveolar ridge preservation: a prospective, randomized, parallel-controlled, single-blind, non-inferiority multicenter clinical trial
Clinical Oral Investigations · 04.06.2026 · 30 (6)
DOI: 10.1007/s00784-026-06921-9 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Oral Investigations, online erschienen am 04.06.2026. Verfasst von Yang Xue und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Oral Diseases, State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Shaanxi Clinical R…. Hauptthemen laut MEDLINE: Hyaluronic Acid, Durapatite, Alveolar Ridge Augmentation, Bone Substitutes. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: Evaluate the efficacy and safety of the combination of sodium hyaluronate and hydroxyapatite for alveolar ridge preservation in fresh extraction sockets with bone defects. MATERIALS AND METHODS: A total of 200 patients, who required tooth extraction due to dental, periodontal, or periapical diseases, were enrolled in five dental clinic centers across China. Alveolar bone defects were identified, and bone grafting was indicated for defects with a depth of ≥ 3 mm on one or more sides of the affected tooth's bone wall, as measured by Cone Beam CT (CBCT). Participants were randomly and equally assigned to either the experimental group, which received hydroxyapatite composite sodium hyaluronate (HAp/HA) implants in the fresh tooth extraction socket, or the control group, which was given a reference bone substitute. Postoperative follow-up assessments were conducted for up to 24 weeks. Changes in alveolar ridge height and width at the implantation site were evaluated blindly using CBCT. Simultaneously, the local healing condition and systemic safety profiles were evaluated. RESULTS: HAp/HA exhibits superior adhesion, facilitating easier filling and shaping during dental procedures in comparison to control material. Postoperative CBCT images, performed right after the operation and at the 24-week follow-up, showed a minimal alteration in alveolar ridge height (-0.33 ± 1.74 mm) and width (-0.60 ± 1.95 mm) subsequent to HAp/HA implantation, indicating no significant variance when compared to the control material. At the 24-week follow-up, the osseointegration of the implanted material with the alveolar bone was scored using a 3-grade system, with the HAp/HA group showing slightly higher average scores than the control group, though not statistically significant. No post-operative infections or material rejections were observed in either group. CONCLUSIONS: HAp/HA can be an effective and safe material for alveolar ridge preservation in tooth extraction sockets with defects. CLINICAL RELEVANCE: Hydroxyapatite composite sodium hyaluronate possess clinical value for alveolar ridge preservation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Clinical Research Center for Oral Diseases, State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial…
- Engineering Research Center of Western Resource Innovation Medicine Green Manufacturing, Shaanxi Key Laboratory of Biomaterials and Synthetic Biology, Shaanxi R&D Center of Biomaterials and Fermentation Engineering, Xi'…
- Department of Stomatology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
- Department of Periodontology, Affiliated Stomatological Hospital, Nanjing Medical University, Nanjing, China.
- Department of Oral Mucosal Diseases, Hospital of Stomatology, Xi'an Jiaotong University, Xi'an, China.
- Department of Stomatology, Xuzhou Central Hospital (Southeast University Affiliated Hospital), Xuzhou, China.
Zitieren
APA
Xue, Y., Liu, L., Xue, C., Sun, Y., Wang, B., Meng, J., & Zhou, H. (2026). Hydroxyapatite composite sodium hyaluronate for alveolar ridge preservation: a prospective, randomized, parallel-controlled, single-blind, non-inferiority multicenter clinical trial. Clinical Oral Investigations, 30(6). https://doi.org/10.1007/s00784-026-06921-9
Vancouver
Xue Y, Liu L, Xue C, Sun Y, Wang B, Meng J, et al. Hydroxyapatite composite sodium hyaluronate for alveolar ridge preservation: a prospective, randomized, parallel-controlled, single-blind, non-inferiority multicenter clinical trial. Clinical Oral Investigations. 2026;30(6). doi:10.1007/s00784-026-06921-9
BibTeX
@article{Xue2026,
author = {Xue, Yang and Liu, Lin and Xue, Chang'ao and Sun, Ying and Wang, Baoyan and Meng, Jian and Zhou, Hongzhi},
title = {Hydroxyapatite composite sodium hyaluronate for alveolar ridge preservation: a prospective, randomized, parallel-controlled, single-blind, non-inferiority multicenter clinical trial},
journal = {Clinical Oral Investigations},
year = {2026},
volume = {30},
number = {6},
doi = {10.1007/s00784-026-06921-9}
}
EUVIMED